beta
Trial Radar AI
I can help you find nearby clinical trials and understand health conditions and treatments.
33 Results
 
Status (Default)
Not yet Recruiting, Recruiting, Active, Not Recruiting
×
 
Keywords
Muscle Mass, Body Composition
×
 
Intervention
GLP-1
×
 
Study Title
Status
Effect of GLP-1 Receptor Agonists on Body Composition in Obesity: The Role of Dietary Protein Consumption in Muscle Mass Maintenance (LEAN-PRO GLP-1) NCT07495904
Recruiting
Strength Training Response of Muscle in GLP-1 Users (STRONG-GLP) NCT07104539
Recruiting
Effect of a Food for Special Medical Purposes on Muscle Mass Preservation During GLP-1 RAs Weight Loss Treatment (MYO-PRESERVE) NCT07393360
Recruiting
Increased Dietary Protein Intake During GLP-1 Medication Use (in Middle-aged Women With Overweight/Obesity) NCT07480109
Not yet recruiting
Comparison of Body Composition Changes With Weight Loss Interventions (REFORM) NCT07115069
Recruiting
Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Therapy and Exercise Training in People With Obesity NCT07091500
Recruiting
Body Composition and Exercise to Prevent Muscle Loss With GLP1 Agonist Treatment (BICEP) NCT07226947
Recruiting
GLP-1R Actions on Muscle and the Skeleton (GRAMS) NCT07154719
Not yet recruiting
Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass (GLIMMER) NCT07272837
Not yet recruiting
Function and Lean Mass Preservation With Resistance Exercise During a GLP-1RA Treatment (FLEX) NCT07457437
Recruiting
Lifestyle Change Implementation Research Network at PRC at UMass Chan (LCIRN) NCT07481305
Not yet recruiting
Probiotic Intervention for Digestive Health in Obese Patients Initiating GLP-RA Treatment (PROBIO-GLP1) NCT07213323
Not yet recruiting
Testing the Efficacy, Safety, and PK of 20E in Patients With Obesity Who Are Starting Treatment With the GLP-1 Agonist Semaglutide for Weight Loss. (OBA) NCT07411378
Not yet recruiting
Assessing Biological Aging in a Real-World Medical Weight Loss Program Using the LinAge2 Clinical Clock NCT07444073
Not yet recruiting
Tirzepatide and Muscle Outcomes in Obesity (TIRMO) NCT07373834
Recruiting
Prevention of Progression of Prediabetes, Obesity and CV Risk (Pre-DM) NCT06446531
Recruiting
CRAVE Study: Comparing Craving Responses and Diet Quality of GLP1 Receptor Agonist Users NCT06467604
Active, not recruiting
The Effect of Pharmacotherapy With GLP-1 and GIP/GLP-1 Analogs on Changes in Qualitative and Quantitative Parameters of the Diet as Well as Metabolic and Behavioral Parameters in Patients With Excess Body Weight NCT07270497
Recruiting
Study of Patients Being Treated With Anti-obesity Medication NCT06790160
Recruiting
Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss (PLATEAU) NCT07446998
Recruiting
Genetics of the Acute Response to Oral Semaglutide (GAROS) NCT05340868
Recruiting
A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity (BMT-801) NCT06565611
Active, not recruiting
A Study of the Effect of (S)-Pindolol Benzoate (ACM-001.1) on Lean Body Mass (LBM) in Obese Patents During (PROACT 1), and Post-semaglutide Therapy (PROACT 2) NCT07101939
Recruiting
Effect of Tirzepatide and Bimagrumab on Body Composition, Insulin Sensitivity, and Bone in Adults With Obesity NCT05933499
Recruiting
Young Adults With Early-onset Obesity Treated With Semaglutide (RESETTLE) NCT05574439
Recruiting
Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD (ADIPO-CKD) NCT07309094
Recruiting
The Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Kidney Transplant Recipients (HALLMARK) NCT05938712
Recruiting
Effect of Semaglutide and Tirzepatide Combined With Exercise in Obesity NCT07319975
Not yet recruiting
The Effect of Exercise and Tirzepatide on Weight and Health Outcomes (EXER-MED) NCT07298915
Not yet recruiting
GLP-1s to Enhance Lasting Optimal Weight (GLOW) NCT06861439
Active, not recruiting
Food and Fitness With Medicine (FFWM) NCT07027995
Recruiting
Evaluating Anti-Obesity Medications 6 Months After Metabolic Surgery NCT07163650
Recruiting
Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 Diabetes NCT05553093
Recruiting